The effect of activation of angiogenesis pathways independent of VEGF in renal cell carcinoma on resistance to VEGF-targeted antiangiogenic therapy.

被引：0
|
作者：
Han, Kyung Seok [1 ]
Gust, Kilian [1 ]
Awrey, Shannon [1 ]
Raven, Peter A. [1 ]
Li, Estelle [1 ]
Fazli, Ladan [1 ]
Gleave, Martin E. [1 ]
So, Alan I. [1 ]
机构：
[1] Vancouver Prostate Ctr, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.409
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
409
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Discontinuing VEGF-targeted therapy (VEGF-TT) for progression versus toxicity impacts outcomes of second-line therapies in metastatic renal cell carcinoma (mRCC).
    de Velasco, Guillermo
    Xie, Wanling
    Donskov, Frede
    Albiges, Laurence
    Beuselinck, Benoit
    Srinivas, Sandhya
    Agarwal, Neeraj
    Lee, Jae-Lyun
    Brugarolas, James
    Wood, Lori
    Kollmannsberger, Christian K.
    Rha, Sun Young
    North, Scott A.
    Kanesvaran, Ravindran
    Rini, Brian I.
    Broom, Reuben James
    Yamamoto, Haru
    Kaymakcalan, Marina Dusevic
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [32] Array-comparative genomic hybridization to predict resistance to VEGF-targeted therapies in patients with metastatic clear cell renal cell carcinoma.
    Kammerer-Jacquet, Solene-Florence
    Dugay, Frederic
    Cluzeau, Laurence
    Brunot, Angelique
    Dagher, Julien
    Peyronnet, Benoit
    Mathieu, Romain
    Verhoest, Gregory
    Bensalah, Karim
    Laguerre, Brigitte
    Kerbrat, Pierre
    Dupuis, Frantz
    Bernard, Jean-Christophe
    Yacoub, Mokrane
    Ravaud, Alain
    Rioux-Leclercq, Nathalie
    Belaud-Rotureau, Marc-Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] Updated results of a prospective noninterventional study of everolimus after failure of the first VEGF-targeted therapy.
    Staehler, Michael D.
    Goebell, Peter J.
    Kube, Ulrich
    Kindler, Manfred
    Koepke, Thomas
    Janssen, Jan
    Schmitz, Joerg
    Weikert, Steffen
    Kloss, Susanne
    Steiner, Gabriel
    Jakob, Andreas
    Steiner, Thomas
    Overkamp, Friedrich
    Bergmann, Lothar
    Guderian, Gernot
    Doehn, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [34] The mechanisms of anti-VEGF therapy resistance in renal cell carcinoma
    Zhou, Lijun
    Liu, Xiande
    Sun, Mianen
    Tannir, Nizar M.
    Laird, Douglas
    Jonasch, Eric
    CANCER RESEARCH, 2014, 74 (19)
  • [35] The mechanisms of anti-VEGF therapy resistance in renal cell carcinoma
    Zhou, Lijun
    Liu, Xiande
    Sun, Mianen
    Tannir, Nizar M.
    Laird, Douglas
    Jonasch, Eric
    ANGIOGENESIS, 2014, 17 (03) : 774 - 774
  • [36] The role of angiogenic signatures in advanced urothelial carcinoma (aUC) treated with VEGF-targeted therapy
    Jackson-Spence, F. E.
    Ackerman, C.
    Khan, M.
    Grant, M.
    Soosaipillai, G.
    Nally, E.
    Choy, J.
    Powles, T. B.
    Szabados, B. E.
    EUROPEAN UROLOGY, 2021, 79 : S636 - S636
  • [37] Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)
    C Seidel
    J Busch
    S Weikert
    S Steffens
    C Bokemeyer
    V Grünwald
    British Journal of Cancer, 2013, 109 : 2998 - 3004
  • [38] Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)
    Seidel, C.
    Busch, J.
    Weikert, S.
    Steffens, S.
    Bokemeyer, C.
    Gruenwald, V.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 2998 - 3004
  • [39] Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
    De Velasco, Guillermo
    Xie, Wanling
    Donskov, Frede
    Albiges, Laurence
    Beuselinck, Benoit
    Srinivas, Sandy
    Agarwal, Neeraj
    Lee, Jae Lyun
    Brugarolas, James
    Wood, Lori A.
    Rha, Sun-young
    Kollmannsberger, Christian
    North, Scott
    Kanesvaran, Ravindran
    Rini, Brian I.
    Broom, Reuben
    Yamamoto, Haru
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : 403 - 410
  • [40] Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma
    Cho, Daniel C.
    Puzanov, Igor
    Regan, Meredith M.
    Schwarzberg, Talya
    Seery, Virginia
    Lee, Mee-Young
    Liu, Vivian
    Bhatt, Rupal
    Koon, Henry
    Mier, James W.
    Sosman, Jeffrey A.
    Atkins, Michael B.
    McDermott, David F.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (02) : 181 - 185
12345